Shows
RealTalk MSFrom the International Progressive MS Alliance Digital Tools Workshop -- Part Two Over the past few months, we've shared news about an algorithm that can accurately predict whether someone living with MS will experience worsening symptoms or a relapse in the weeks ahead. You've heard about a three-quarter-of-a-million-dollar investment by the International Progressive MS Alliance to support the development of an AI-based tool that will predict future disability as well as how someone with MS will respond to different disease-modifying therapies. Just last week, you learned about a digital tool that can accurately diagnose whether someone has relapsing-remitting MS or progressive MS -- after a f...2025-07-0844 min
RealTalk MSThe Importance of Cancer Screenings for People Living with MS With Dr. Ruth Ann MarrieManaging MS means staying focused not only on your MS but also on your overall health. That includes getting routine health screenings to stay ahead of potential complications. Recent research has shown that, compared to healthy people, people with MS are more likely to develop some cancers. Clinician-scientist Dr. Ruth Ann Marrie joins me to discuss which cancers pose a greater risk to someone with MS, why you need to make those appointments for cancer screenings, where you can find low-cost or no-cost cancer screenings, and things you can do to further minimize your risk of...2025-04-0131 min
The ECTRIMS PodcastPrioritising Women's Health Topics in MS ResearchIn a landscape where funding is increasingly difficult to obtain, the importance of conducting research that has the greatest impact has never been more important. In the case of women with MS, a large-scale scoping review,* conducted on behalf of the International Advisory Committee on Clinical Trials in MS, sheds light on the research gaps related to female health. ln this episode, host Brett Drummond of MSTranslate talks with two of its authors -- Lindsay Ross, an assistant professor at the Cleveland Clinic Lerner College of Medicine, and Ruth Ann Marrie, professor of medicine and community health sciences at...2024-04-2029 min
MS Living Well: Key Info from Multiple Sclerosis ExpertsNavigating MS with Other Medical ConditionsLiving with multiple sclerosis isn't just about managing the condition itself, but often involves navigating a myriad of additional health concerns known as comorbidities. Individuals with MS face a higher risk of experiencing new relapses when dealing with comorbidities like high cholesterol or depression. Furthermore, autoimmune diseases such as psoriasis and inflammatory bowel diseases like Crohn’s disease and ulcerative colitis are more prevalent among those with MS. There is even a heightened risk of bladder cancer. Interaction of MS treatments and other common conditions like high blood pressure (hypertension), high cholesterol and diabetes are addressed. Experts sh...2024-03-1942 min
RealTalk MSIt's Our 6th Anniversary! These Are the Most Impactful Conversations We've Had Over the Past Six YearsRealTalk MS is now 6 years old! We've covered a lot of ground in more than 300 episodes over the past 6 years. And I'm marking our 6-year anniversary by highlighting the most impactful conversations we've had in each of the past 6 years. We have a lot to talk about! Are you ready for RealTalk MS??! SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/317 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast...2023-09-2619 min
RealTalk MSBarancik Prize Conversations -- Part 2Welcome to Part 2 of a special two-part RealTalk MS series highlighting conversations with past recipients of the Barancik Prize for Innovation in MS Research. The Barancik Prize is awarded at the annual meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis, a meeting better known as the ACTRIMS Forum. Several past Barancik Prize winners gathered at the 2023 ACTRIMS Forum to celebrate the 10th anniversary of the Barancik Prize, and I took that opportunity to chat with this remarkable group of MS research all-stars. Part 2 of Barancik Prize Conversations features the 2018, 2020, an...2023-04-2037 min
RealTalk MSMeet the Winner of the 2023 Barancik Prize for Innovation in MS Research with Dr. Ruth Ann MarrieLast week in San Diego, the Americas Committee for Treatment and Research in Multiple Sclerosis convened their annual meeting, the ACTRIMS Forum. One of the highlights of this meeting is the presentation of the Barancik Prize, awarded in recognition of exceptional innovation in MS research. This year's winner of the Barancik Prize is Dr. Ruth Ann Marrie, a clinician scientist at the University of Manitoba. The Barancik Prize is administered by the National MS Society, and this year's award recognizes Dr. Marrie's landmark discoveries that deepen our understanding of how and when MS evolves. 2023-02-2833 min
RealTalk MSFinding Support When You're Living with MS with Debby Bennett and Ricky MaxwellMS can sometimes feel isolating. And the ironic thing about those feelings of isolation is that you can experience them even when you're with other people. It's the feeling that, while everyone is being supportive, nobody really gets it. They've never experienced what it's like to actually live with MS. That's why connecting with others who are living with MS can be such a difference-maker. My guests in this episode are Debby Bennett, the Manager of Community Engagement at the National MS Society, and Ricky Maxwell, an MS Society self-help group member and leader, and we're talking...2023-02-0728 min
MS-Perspektive - der Multiple Sklerose PodcastSpezial ECTRIMS 2022 - Tag 2 - Frühe Prognosefaktoren für Behandlungserfolg, Eskalieren und Deeskalieren von Therapien sowie Progrediente MS In der 2. Folge vom ECTRIMS 2022 berichte ich von drei Themenblöcken: Early predictors of treatment outcome / Frühe Prädiktoren für den Behandlungserfolg von Xavier Montalban vom MS Centre of Catalonia Hot Topic 5: Escalating and de-escalating DMTs / Eskalieren und Deeskalieren von verlaufsmodifizierenden Medikamenten Treating active MS following induction therapies / Behandlung der aktiven MS nach Induktionstherapien von Gilles Edan der CHU Renne, Frankreich Long-term stable MS on high-efficacy therapies / Langfristig stabile MS unter hochwirksamen Therapien von Emmanuelle Wubant von der University of California, San Francisco, USA Long-term stable MS on platform therapies / Langfristig stabile MS unter Basi...2022-10-2755 min
RealTalk MSEpisode 232: Managing MS and Comorbidities with Dr. Ruth Ann MarrieResearch shows that about 50% of the people living with MS will develop another chronic health condition, or comorbidity, in their lifetime. Whether it's high blood pressure, diabetes, or something else, living with comorbid conditions adds extra challenges to living with MS. Joining me to discuss how comorbidities affect people living with MS and what you can do to avoid developing some of those comorbidities is one of the leading experts on the subject, Dr. Ruth Ann Marrie. We're also talking about why a Phase 2 clinical trial for a prospective MS disease-modifying therapy got a...2022-02-0829 min
Multiple Sclerosis ResearchDr. John DeLuca Calls for Action on Rehabilitation Research for Progressive Multiple Sclerosis -Ep24Fast Takes Series - Prioritizing Progressive MS Rehabilitation Research - A Call From The International Progressive MS Alliance - Episode 24 Read the transcriptIn this episode, Dr. John DeLuca, senior vice of president for research and training talks about the International Progressive MS Alliance and the peer-reviewed Alliance article “Prioritizing progressive MS rehabilitation research: A call from the International Progressive MS Alliance” published on March 15, 2021 in the journal Multiple Sclerosis Learn more about Dr. DeLuca and the journal articleCo-authors: Kathleen M Zackowski, Jennifer Freeman, Giampaolo Brichetto, Diego Centonze, Ulrik Dalgas, John...2021-08-1005 min
Kessler Foundation PodcastsDr. John DeLuca calls for action on rehabilitation research for progressive multiple sclerosis -Ep24Fast Takes Series - Prioritizing Progressive MS Rehabilitation Research - A Call From The International Progressive MS Alliance - Episode 24
Read the transcript - https://kesslerfoundation.org/sites/default/files/2021-06/Dr.%20John%20DeLuca%20Calls%20for%20Action%20on%20Rehabilitation%20Research%20for%20Progressive%20Multiple%20Sclerosis%20-Ep24.pdf
In this episode, Dr. John DeLuca, senior vice of president for research and training talks about the International Progressive MS Alliance and the peer-reviewed Alliance article “Prioritizing progressive MS rehabilitation research: A call from the International Progressive MS Alliance” published on March 15, 2021 in the journal Multiple Sclerosis
Learn more about: Dr. DeLuca at https://kess...2021-05-2805 min
RealTalk MSRemyelination in MS with Dr. Jeffrey Cohen and Dr. Ian DuncanToday, remyelination holds real promise as a strategy for restoring lost function and slowing or even stopping MS progression. This week, we're taking a deep dive into the current state of remyelination research. Joining me are Dr. Jeffrey Cohen, the Hazel Prior Hostetler Professor of Neurology at the Cleveland Clinic and the director of the Cleveland Clinic’s Mellen Center for Multiple Sclerosis Treatment and Research, and Dr. Ian Duncan, a neuroscientist, and Professor of Neurology at the University of Wisconsin-Madison and the recipient of the 2020 Dystel Prize for MS Research. We're also talking about the publication of the A...2020-11-1733 min
Ariez B.V.Prof. dr. Ruth Ann MarrieEr komt steeds meer bewijs dat metabool syndroom invloed heeft op het risico op MS of de prognose van reeds bestaande MS. Met name obesitas wordt geassocieerd met een verhoogd risico op het ontwikkelen van MS. Prof. Ruth Ann Marrie wijdt in deze podcast uit over het verband tussen metabool syndroom en het ontstaan van MS, het relapspercentage en de ziekteprogressie.2020-11-0505 min
Ariez B.V.prof. dr. Ruth Ann Marrie2020-09-1705 min
RealTalk MSAlmost One Million! The Prevalence of MS with National MS Society CEO Cyndi Zagieboylo, Dr. Bruce Bebo, & Dr. Ruth Ann MarrieIt's MS Awareness Week! And the single event that is likely going to have the most impact in raising awareness of MS in the United States is the recent announcement of the MS Prevalence Study results. The results of this study corrected the decades old notion that there were only about 400,000 people living with MS in the United States. We now know that the number of people living with MS in the U.S. is closer to one million. More than twice as many as had been previously estimated. In this special RealTalk MS episode, we're going to look at MS...2019-03-1239 min
Neurology® PodcastMarch 22 2016 Issue1) Statin pretreatment is associated with better outcomes in large-artery atherosclerotic stroke2) e-Pearl topic: Fatal familial insomnia3) Topic of the month: Pediatric multiple sclerosis This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andy Southerland interviews Dr. Georgios Tsivgoulis about his paper on how statin pretreatment is associated with better outcome in large-artery atherosclerotic stroke. Dr. Steve O'Donnell is reading our e-Pearl of the week about fatal familial insomnia. In the next part of the podcast Dr. Ruth Ann Marrie interviews...2016-03-2120 minNeurology® PodcastMarch 15 2016 Issue1) Metabotropic glutamate receptor type 1 autoimmunity: Clinical features and treatment outcomes2) What's Trending: Editorial on if stress could cause a stroke3) Topic of the month: Pediatric multiple sclerosis This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Kathryn Nevel interviews Dr. Andrew McKeon about his paper on clinical features and treatment outcomes of metabotropic glutamate receptor type 1 autoimmunity. Dr. Ted Burns is interviewing Dr. Jennifer Majersik for our “What's Trending” feature of the week about her editorial on if stress could caus...2016-03-1418 minNeurology® PodcastMarch 1 2016 Issue1) Neurology® Neuroimmunology & Neuroinflammation: Therapy with natalizumab is associated with high JCV sero-conversion and rising JCV index values 2) What's Trending: Interviews with Sandi Moriarity and Andy Lucas about their positions and responsibilities with the Neurology podcasts3) Topic of the month: Pediatric multiple sclerosis This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Melanie Ward interviews Dr. Nicholas Schwab about his Neurology: Neuroimmunology & Neuroinflammation paper on therapy with natalizumab and how it is associated with high JCV sero-conversion and rising JCV index v...2016-03-0125 minNeurology® PodcastJuly 1 2014 Issue1) Long-term safety and effectiveness of natalizumab for re-dosing and treatment of multiple sclerosis and 2) Topic of the month: Plenary sessions AAN Meeting April 2014. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ruth Ann Marrie interviews Dr. Paul O'Connor about his paper on long-term safety and effectiveness of natalizumab for re-dosing and treatment of multiple sclerosis. Dr. James Addington is reading our e-Pearl of the week about inclusion body myositis. In the next part of the podcast Dr. Alberto Espay...2014-07-0128 min